Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome

Key PointsFragile X syndrome is a monogenic neurodevelopmental disorder associated with intellectual disability and autism spectrum disorders.Animal models have provided insights into the neurobiological mechanisms and enabled the identification of novel drug targets.Promising targets include metabo